'United Kingdom', 'U.K. takeover law', 'prohibit.01', 'the U.S. firm', 'from improving', 'Affirmative', "( PFE:US ) 's 69.4 billion - pound ( $ 117 billion ) pursuit of British drugmaker AstraZeneca Plc ( AZN ) is likely to fail because U.K. takeover law prohibits the U.S. firm from improving its offer further after declaring it final , according to people familiar with the transaction . ", 'United States', 'newsText24923'
